Trial Profile
An Open-label Crossover Trial Assessing the Value of Dabigatran in a Drug Interaction Cocktail in Healthy Young Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Aug 2018
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Caffeine; Clarithromycin; Diclofenac; Esomeprazole; Metoprolol; Midazolam
- Indications Deep vein thrombosis; Embolism; Pulmonary embolism; Stroke; Venous thromboembolism
- Focus Pharmacokinetics
- Acronyms D-cocktail
- 10 Aug 2018 Status changed from recruiting to completed.
- 26 Feb 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 18 Feb 2015 New trial record